Additionally, the BE-FAO group had higher bronchiectasis severity, more extensive emphysema, worse airway symptoms, higher CRP levels, lower lung function indices, and greater reliance on bronchodilators than the BE group. The gene discussed is CRP; the disease is pulmonary emphysema.